AnserBio is a startup based in Israel, 1 tracked investor.
AnserBio is a startup founded in 2020 based in Israel. Brouky records 1 investor associated with the company.
AnserBio develops an oncology therapeutic delivery platform using exosomes to deliver healthy p53 protein for restoring tumor suppression in cancers with TP53 gene mutations.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.